Search Results
Tracking a-synuclein pathology - Michael Henderson, PhD
Michael Henderson, PhD. discusses FDA approval of Alzheimer's drug
Webinar 11: Career advice from Dr Malú Tansey, Dr Laura Volpicelli-Daley, and Dr Michael Henderson.
α-synuclein seed amplification assay for diagnosing Parkinson's disease
Alpha-synuclein as a therapeutic target for Parkinson’s disease: challenges and opportunities
Alpha-synuclein Aggregation in Parkinson's Disease - Is it Relevant and How can we Model it?
ONDRI Community Engagement Day 2021/22 - complete event recording
Prasinezumab: an anti-alpha-synuclein antibody in Parkinson's disease
Research Q & A (Session 2) - moderator: Jeffrey Kordower, PhD
Ask the PhD: Pursuit of a Game-changing Brain Scan for Parkinson's
Basal Ganglia & Alpha Synuclein Diseases
Van Andel Institute Public Lecture Series: Parkinson’s Disease — From Genes to the Clinic
